United States· US:85304-031_4eefbef4-7644-dca4-e063-6394a90a72c1
TAGOQHIA Extra Strength NAIL REPAIR PEN
A medicinal product containing undecylenic acid; tolnaftate, registered in United States by Guangzhou Borderless Technology Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- UNDECYLENIC ACID; TOLNAFTATE
- Manufacturer
- Guangzhou Borderless Technology Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1185304-031-01
- ndc1185304031013 BOTTLE, WITH APPLICATOR in 1 PACKAGE (85304-031-01) / 15 mL in 1 BOTTLE, WITH APPLICATOR
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1749cc10-1836-4d60-97c9-ea0e6661be99 GET /v1/drugs/1749cc10-1836-4d60-97c9-ea0e6661be99?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "25; 1",
"substance": "UNDECYLENIC ACID; TOLNAFTATE",
"productndc": "85304-031",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL",
"application_number": "M005",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about undecylenic acid; tolnaftate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.